Evidence map›Paper›PMID 35714301›Full record

ArticleJCO clinical cancer informatics2022

Deep Learning for Cancer Symptoms Monitoring on the Basis of Electronic Health Record Unstructured Clinical Notes.

Charlotta Lindvall, Chih-Ying Deng, Nicole D Agaronnik, Anne Kwok, Soujanya Samineni, Renato Umeton, Warren Mackie-Jenkins, Kenneth L Kehl, James A Tulsky, Andrea C Enzinger

Open access · greenAbstract read
In one paragraph

Article in JCO clinical cancer informatics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. CACER: Clinical concept Annotations for Cancer Events and Relations.Journal of the American Medical Informatics Association : JAMIA · 2024
    Article
  10. Article
  11. Article
  12. Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force.Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2024
    Article
  13. Review
  14. Article
  15. Promise and Perils of Large Language Models for Cancer Survivorship and Supportive Care.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Charlotta LindvallDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-2090-2039
Chih-Ying DengDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-2938-0417
Nicole D AgaronnikDana-Farber Cancer Institute, Boston, MA.
Anne KwokDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-0948-9482
Soujanya SamineniDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0003-1056-8006
Renato UmetonDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0002-5561-6932
Warren Mackie-JenkinsDana-Farber Cancer Institute, Boston, MA.
Kenneth L KehlDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-5339-9797
James A TulskyDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0002-7458-0453
Andrea C EnzingerDana-Farber Cancer Institute, Boston, MA.ORCID 0000-0001-7502-8081
Brigham and Women's Hospital · USDana-Farber Cancer Institute · USHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSymptoms are vital outcomes for cancer clinical trials, observational research, and population-level surveillance. Patient-reported outcomes (PROs) are valuable for monitoring symptoms, yet there are many challenges to collecting PROs at scale. We sought to develop, test, and externally validate a deep learning model to extract symptoms from unstructured clinical notes in the electronic health record.

methodsWe randomly selected 1,225 outpatient progress notes from among patients treated at the Dana-Farber Cancer Institute between January 2016 and December 2019 and used 1,125 notes as our training/validation data set and 100 notes as our test data set. We evaluated the performance of 10 deep learning models for detecting 80 symptoms included in the National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) framework. Model performance as compared with manual chart abstraction was assessed using standard metrics, and the highest performer was externally validated on a sample of 100 physician notes from a different clinical context.

resultsIn our training and test data sets, 75 of the 80 candidate symptoms were identified. The ELECTRA-small model had the highest performance for symptom identification at the token level (ie, at the individual symptom level), with an F1 of 0.87 and a processing time of 3.95 seconds per note. For the 10 most common symptoms in the test data set, the F1 score ranged from 0.98 for anxious to 0.86 for fatigue. For external validation of the same symptoms, the note-level performance ranged from F1 = 0.97 for diarrhea and dizziness to F1 = 0.73 for swelling.

conclusionTraining a deep learning model to identify a wide range of electronic health record-documented symptoms relevant to cancer care is feasible. This approach could be used at the health system scale to complement to electronic PROs.

Indexed as

Deep LearningNeoplasmsElectronic Health RecordsFatigueHumansPatient Reported Outcome Measures

Identifiers

PMID35714301
PMCPMC9232368
OpenAlexW4283071620

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.